Login

Reflecting on My Failure to Make Gumroad a Billion Dollar Company|Sahil Lavingia,Founder,SHL Capital 00:10:00

Share On Facebook Share On Twitter

Founder and CEO of Gumroad. Previously, he was early at Pinterest.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
early-stage investments in technology sector give a huge profit in near future|George Zachary,General Partner,CRV
00:10:00
Interactive Brokers Chairman discusses the company's Q2 earnings beat.
00:10:00
Introduction to Social Enterprise: Legal Structures and Funding Strategies
00:10:00
Cerro De Pasco Resources CEO Guy Goulet Presents at Metals Investor Forum 2023 | Guy Goulet, CHIEF EXECUTIVE OFFICER of Cerro de Pasco Resources Inc.
00:10:00
Terramin Australia Ltd.'s Exploration and Development Plans Highlighted
00:10:00
DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives.
00:10:00
Results of a Pompe disease treatment trial are discussed by John Crowley | Bradley L. Campbell, PRESIDENT AND CHIEF EXECUTIVE OFFICER , AMICUS THERAPEUTICS, INC.
00:10:00
MARKT Update: Gold Reaches Record Highs Amidst Economic Shifts
00:10:00
Shares the early influence and the core foundation of hard-working values|Andy Ziolkowski,Managing Partner,Cultivian Sandbox Ventures
00:10:00
Dr. Axel Kaufmann, Board Member and CFOO of Nemetschek SE, delivers an elevator pitch, while Ronald Slabke, CEO of Hypoport SE, provides a testimonial.
00:10:00
Sam Garrett Outlines Great Southern Copper's Ambitious Future in Chilean Copper Exploration | Sam Garrett, CEO, Great Southern Copper PLC.
00:10:00
Apella’s James Femia explains the importance of early college planning during a child's Freshman or Sophomore year of high school for an effective financial strategy.|Patrick A. Sweeny is a founding partner of Apella Capital.

© 2017 - Neuhu+